HOMA2-%B (beta cell function) — what it means and how to interpret it Biomarker Testing
HOMA2-%B estimates your pancreas’s insulin-secreting beta cell function from fasting glucose and insulin, with easy ordering through Vitals Vault/Quest.
With Vitals Vault, you have access to a comprehensive range of biomarker tests.
HOMA2-%B is a calculated marker that estimates how hard your pancreas’s beta cells are working to make insulin. It is reported as a percentage compared with a reference “healthy” population, so it is meant to be interpreted as a relative estimate rather than a direct measurement.
This number can be especially helpful when your glucose is drifting up, your fasting insulin is high, or you are trying to understand whether insulin resistance, reduced insulin production, or both are driving your blood sugar pattern.
Because it is derived from fasting glucose and fasting insulin, the context matters. Your result is most useful when you look at it alongside A1c, triglycerides, HDL, and your overall metabolic picture.
Do I need a HOMA2-%B test?
You may consider HOMA2-%B if you are trying to make sense of early metabolic changes, such as rising fasting glucose, a borderline A1c, or a fasting insulin that seems higher than expected. It can also be useful if you have symptoms that can show up as glucose control worsens over time, including fatigue, increased thirst, or more frequent urination.
HOMA2-%B is also a practical add-on when you want to separate two common drivers of abnormal glucose: insulin resistance (your cells do not respond well to insulin) versus beta cell decline (your pancreas cannot keep up with insulin demand). Knowing which pattern fits you can change what you focus on next.
If you already have diagnosed diabetes or you are on insulin or certain glucose-lowering medications, HOMA2-%B can be harder to interpret because the inputs may not reflect your baseline physiology. In those cases, it can still add context, but it should be read with your clinician.
This test supports clinician-directed care and informed self-advocacy, but it cannot diagnose diabetes type or replace medical evaluation on its own.
HOMA2-%B is a derived index calculated from fasting glucose and fasting insulin using the HOMA2 model; it is not a standalone diagnosis.
Lab testing
Order fasting labs that support HOMA2-%B calculation
Schedule online, results typically within about a week
Clear reporting and optional clinician context
HSA/FSA eligible where applicable
Get this test with Vitals Vault
With Vitals Vault, you can order labs that include the inputs used to calculate HOMA2-%B and then review your results in one place. If you are tracking metabolic health, this can help you move from “a single number” to a clearer pattern over time.
After your results post, PocketMD can help you understand what your HOMA2-%B suggests about insulin secretion relative to your fasting glucose and insulin, and which companion markers are most relevant to check next.
If you are making lifestyle changes or working with a clinician on a plan, repeating fasting labs under similar conditions can help you see whether your beta cell workload is improving, staying stable, or trending in the wrong direction.
- Order labs directly and choose a convenient draw location
- PocketMD explanations built around your results and context
- Easy retesting to track trends over time
Key benefits of HOMA2-%B testing
- Estimates how much insulin your pancreas is producing relative to a reference healthy population.
- Helps distinguish insulin resistance patterns from beta cell decline when glucose is abnormal.
- Adds context when fasting glucose or A1c is borderline but you want earlier insight.
- Can highlight “compensated” states where insulin output is high even before glucose rises.
- Supports more targeted follow-up testing, such as A1c, lipids, and inflammation markers.
- Helps you monitor whether changes in diet, weight, sleep, or activity reduce beta cell strain.
- Pairs naturally with PocketMD guidance so you can interpret the index alongside your full panel.
What is HOMA2-%B?
HOMA2-%B is an estimate of pancreatic beta cell function. Beta cells are the insulin-producing cells in your pancreas, and insulin is the hormone that helps move glucose from your bloodstream into your tissues for energy or storage.
HOMA2-%B comes from the HOMA2 (Homeostatic Model Assessment 2) model, which uses your fasting glucose and fasting insulin to estimate how much insulin secretion is happening at baseline. The “%B” part is expressed as a percentage relative to a reference population, so it is best thought of as an index rather than a direct measurement of beta cell mass or insulin output.
In early insulin resistance, your beta cells often compensate by producing more insulin to keep glucose normal. Over time, beta cell function can decline, and glucose may rise because insulin production can no longer keep up. HOMA2-%B can help you see where you may be along that spectrum, especially when interpreted with other metabolic markers.
How HOMA2-%B is calculated
Formula
HOMA2 Model (Fasting Glucose, Fasting Insulin)
Labs calculate HOMA2-%B using a validated mathematical model that takes your fasting glucose and fasting insulin as inputs. Because it is model-based, different labs may present the value with slightly different rounding or reference interpretation, but the core inputs are the same.
For the most meaningful result, your blood draw should be truly fasting and done when you are not acutely ill. If your insulin is affected by medications or non-fasting intake, the calculated index may not reflect your baseline beta cell function.
What do my HOMA2-%B results mean?
Low HOMA2-%B
A low HOMA2-%B generally suggests reduced beta cell function, meaning your pancreas may not be producing enough insulin for your body’s needs. This can happen as type 2 diabetes progresses, but it can also occur with autoimmune-related beta cell damage (sometimes discussed as LADA or “type 1.5”).
Low values are most concerning when they line up with higher fasting glucose, higher A1c, or symptoms such as increased thirst, frequent urination, and fatigue. If your result is low, it is usually worth reviewing it alongside fasting glucose, A1c, and (when appropriate) additional testing your clinician recommends.
In-range / expected HOMA2-%B
An in-range HOMA2-%B suggests your beta cells are producing insulin at a level that is broadly consistent with the model’s reference expectations for fasting conditions. This does not automatically mean you have no metabolic risk, because you can still have insulin resistance with normal glucose if your pancreas is compensating.
Your best interpretation comes from pairing HOMA2-%B with fasting insulin (to see how hard your pancreas is working), fasting glucose and A1c (to see the glucose outcome), and lipids such as triglycerides and HDL (to see the broader metabolic pattern).
High HOMA2-%B
A high HOMA2-%B often reflects higher insulin secretion in the fasting state. In many people, that pattern fits early or “compensated” insulin resistance, where your pancreas is producing extra insulin to keep fasting glucose from rising.
A high value can be a useful early signal even when glucose and A1c look acceptable, because chronically high insulin output may indicate increased metabolic strain. Over time, some people move from high insulin output to declining output, so trends across repeat tests can be more informative than a single snapshot.
Factors that influence HOMA2-%B
Because HOMA2-%B is calculated from fasting glucose and fasting insulin, anything that changes those inputs can shift your result. Recent food intake, poor sleep, acute stress, infection, and intense exercise shortly before the draw can raise glucose and/or insulin and distort the estimate.
Medications can also affect interpretation, especially insulin, insulin secretagogues, and other glucose-lowering therapies. Longer-term factors such as genetics, excess visceral fat, lipotoxicity (fat-related stress on beta cells), and glucotoxicity (chronic high glucose) can contribute to declining beta cell function over time.
Frequently Asked Questions
What does HOMA2-%B measure?
HOMA2-%B estimates pancreatic beta cell function, which is your body’s insulin-secreting capacity at baseline. It is calculated from fasting glucose and fasting insulin using the HOMA2 model and reported as a percentage relative to a reference healthy population.
Do I need to fast for HOMA2-%B?
Yes. Because HOMA2-%B is derived from fasting glucose and fasting insulin, fasting is essential for meaningful interpretation. If you are not truly fasting, insulin and glucose can be elevated from recent intake and the calculated index may not reflect your baseline physiology.
Is HOMA2-%B the same as HOMA-IR?
No. HOMA-IR is an index that estimates insulin resistance, while HOMA2-%B estimates beta cell insulin secretion function. They are related because insulin resistance often pushes beta cells to produce more insulin, but they answer different questions.
Can HOMA2-%B tell me if I have type 1 or type 2 diabetes?
It cannot diagnose diabetes type on its own. A low HOMA2-%B can be consistent with beta cell failure that may occur in later type 2 diabetes or autoimmune-related diabetes, but diagnosis typically requires a full clinical evaluation and sometimes additional labs.
Why could my HOMA2-%B be high if my glucose is normal?
If your tissues are less sensitive to insulin, your pancreas may compensate by secreting more insulin to keep glucose in range. That higher fasting insulin can drive a higher HOMA2-%B even before fasting glucose or A1c becomes abnormal.
What other labs should I look at with HOMA2-%B?
HOMA2-%B is most useful alongside fasting glucose, fasting insulin, and A1c to understand both insulin output and glucose outcomes. Many people also review lipids (especially triglycerides and HDL) to assess the broader metabolic pattern.
How often should I retest HOMA2-%B?
There is no single schedule that fits everyone, but retesting can be helpful after you have made sustained changes that could affect insulin and glucose, such as weight loss, diet adjustments, or changes in activity and sleep. The key is to repeat the test under similar fasting conditions so trends are interpretable.